UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

An individualized patient-reported outcome measure (PROM) based patient decision aid and surgeon report for patients considering total knee arthroplasty: protocol for a pragmatic randomized controlled trial

BMC musculoskeletal disorders, 2019-02, Vol.20 (1), p.89-89, Article 89

2019

Volltextzugriff (PDF)

An online individualised patient decision aid improves the quality of decisions in patients considering total knee arthroplasty in routine care: A randomized controlled trial

Osteoarthritis and cartilage open, 2022-09, Vol.4 (3), p.100286-100286, Article 100286

2022

Volltextzugriff (PDF)

Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine

Value in health, 2017, Vol.20 (1), p.32-39

2017

Volltextzugriff (PDF)

Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation

Therapeutic advances in chronic disease, 2024-01, Vol.15, p.20406223241239168-20406223241239168

2024

Volltextzugriff (PDF)

S871 Patient Satisfaction With and Access to Virtual Healthcare for Inflammatory Bowel Disease During the COVID-19 Pandemic

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e628-e629

2022

Volltextzugriff (PDF)

Impact of an online, individualised, patient reported outcome measures based patient decision aid on patient expectations, decisional regret, satisfaction, and health‐related quality‐of‐life for patients considering total knee arthroplasty: Results from a randomised controlled trial

Journal of evaluation in clinical practice, 2023-04, Vol.29 (3), p.513-524

2023

Volltextzugriff (PDF)

(Un)standardized testing: the diagnostic odyssey of children with rare genetic disorders in Alberta, Canada

Genetics in medicine, 2021-02, Vol.23 (2), p.272-279

2021

Volltextzugriff (PDF)

Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies

PharmacoEconomics, 2023-12, Vol.41 (12), p.1563-1588

2023

Volltextzugriff (PDF)

The value of diagnostic testing for parents of children with rare genetic diseases

Genetics in medicine, 2019-12, Vol.21 (12), p.2798-2806

2019

Volltextzugriff (PDF)

OP168 Costs And Effectiveness Of Whole Exome Sequencing (WES) In Patients With Unsolved Rare Disease Through The Diagnostic Pathway

International journal of technology assessment in health care, 2023-12, Vol.39 (S1), p.S50-S50

2023

Volltextzugriff (PDF)

How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment

BMJ open, 2016-06, Vol.6 (6), p.e010981-e010981

2016

Volltextzugriff (PDF)

Estimating the Burden of Osteoarthritis to Plan for the Future

Arthritis care & research (2010), 2015-10, Vol.67 (10), p.1379-1386

2015

Volltextzugriff (PDF)

The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy

European journal of cancer (1990), 2016-07, Vol.61, p.85-93

2016

Volltextzugriff (PDF)

Direct health-care costs for children diagnosed with genetic diseases are significantly higher than for children with other chronic diseases

Genetics in medicine, 2019-05, Vol.21 (5), p.1049-1057

2019

Volltextzugriff (PDF)

What are people willing to pay for whole-genome sequencing information, and who decides what they receive?

Genetics in medicine, 2016-12, Vol.18 (12), p.1295-1302

2016

Volltextzugriff (PDF)

Methods for Conducting Stated Preference Research with Children and Adolescents in Health: A Scoping Review of the Application of Discrete Choice Experiments

The patient : patient-centered outcomes research, 2021-11, Vol.14 (6), p.741-758

2021

Volltextzugriff (PDF)

Symptom onset, diagnosis and management of osteoarthritis

Health reports, 2014-09, Vol.25 (9), p.10-17

2014

Volltextzugriff (PDF)

Correction: The value of diagnostic testing for parents of children with rare genetic diseases

Genetics in medicine, 2019-11, Vol.21 (11), p.2662-2662

2019

Volltextzugriff (PDF)

Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology

Personalized medicine, 2015-01, Vol.12 (1), p.13-22

2015

Volltextzugriff (PDF)

The price of whole-genome sequencing may be decreasing, but who will be sequenced?

Personalized medicine, 2017-05, Vol.14 (3), p.203-211

2017

Volltextzugriff (PDF)

OP21 Patient Values Project (PVP): Patient Preferences For Cancer Treatments To Inform A Framework Incorporating Patient Values Into Health Technology Assessment

International journal of technology assessment in health care, 2023-12, Vol.39 (S1), p.S6-S7

2023

Volltextzugriff (PDF)

Mo1915 A MULTICENTER, DOUBLE BLINDED, RANDOMIZED PILOT TRIAL COMPARING FECAL MICROBIOTA TRANSPLANTATION (FMT) TO PLACEBO AT INCUDING CLINICAL AND ENDOSCOPIC REMISSION IN MILD TO MODERATE CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1170-S-1171

2024

Volltextzugriff (PDF)

40 EFFECTS OF LYOPHILIZED FECAL FILTRATE COMPARED TO LYOPHILIZED DONOR STOOL IN THE TREATMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A MULTI-CENTER, DOUBLEBLINDED RANDOMIZED TRIAL

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-15-S-16

2024

Volltextzugriff (PDF)

Wrong or Unexpected? Using Internal Validity Tests to Understand Stated Preference Survey Results

The patient : patient-centered outcomes research, 2022-11, Vol.15 (6), p.737-737

2022

Volltextzugriff (PDF)

Dual Best-Worst Scaling: A New Method to Support Importance-Performance Analysis of Health Services

The patient : patient-centered outcomes research, 2023-07, Vol.16 (4), p.401-401

2023

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(81)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An individualized patient-reported outcome measure (PROM) based patient decision aid and surgeon report for patients considering total knee arthroplasty: protocol for a pragmatic randomized controlled trial

An online individualised patient decision aid improves the quality of decisions in patients considering total knee arthroplasty in routine care: A randomized controlled trial

Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine

Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation

S871 Patient Satisfaction With and Access to Virtual Healthcare for Inflammatory Bowel Disease During the COVID-19 Pandemic

Impact of an online, individualised, patient reported outcome measures based patient decision aid on patient expectations, decisional regret, satisfaction, and health‐related quality‐of‐life for patients considering total knee arthroplasty: Results from a randomised controlled trial

(Un)standardized testing: the diagnostic odyssey of children with rare genetic disorders in Alberta, Canada

Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies

The value of diagnostic testing for parents of children with rare genetic diseases

OP168 Costs And Effectiveness Of Whole Exome Sequencing (WES) In Patients With Unsolved Rare Disease Through The Diagnostic Pathway

How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment

Estimating the Burden of Osteoarthritis to Plan for the Future

The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy

Direct health-care costs for children diagnosed with genetic diseases are significantly higher than for children with other chronic diseases

What are people willing to pay for whole-genome sequencing information, and who decides what they receive?

Methods for Conducting Stated Preference Research with Children and Adolescents in Health: A Scoping Review of the Application of Discrete Choice Experiments

Symptom onset, diagnosis and management of osteoarthritis

Correction: The value of diagnostic testing for parents of children with rare genetic diseases

Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology

The price of whole-genome sequencing may be decreasing, but who will be sequenced?

OP21 Patient Values Project (PVP): Patient Preferences For Cancer Treatments To Inform A Framework Incorporating Patient Values Into Health Technology Assessment

Mo1915 A MULTICENTER, DOUBLE BLINDED, RANDOMIZED PILOT TRIAL COMPARING FECAL MICROBIOTA TRANSPLANTATION (FMT) TO PLACEBO AT INCUDING CLINICAL AND ENDOSCOPIC REMISSION IN MILD TO MODERATE CROHN'S DISEASE

40 EFFECTS OF LYOPHILIZED FECAL FILTRATE COMPARED TO LYOPHILIZED DONOR STOOL IN THE TREATMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A MULTI-CENTER, DOUBLEBLINDED RANDOMIZED TRIAL

Wrong or Unexpected? Using Internal Validity Tests to Understand Stated Preference Survey Results

Dual Best-Worst Scaling: A New Method to Support Importance-Performance Analysis of Health Services

Suchergebnisse filtern